Compositions and methods for increasing erythropoietin (EPO) production
US10233452B2 · kind B2 · utility
0Cited by
0References
25Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 19, 2015 |
| Grant date | Mar 19, 2019 |
| Priority date | — |
| Expiry date | Oct 19, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y114/11002
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to double-stranded ribonucleic acid (dsRNA) compositions targeting one or more EGLN genes, EGLN1, EGLN2 and/or EGLN3 and methods of using such dsRNA compositions to inhibit expression of these genes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.